Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Index to Volume 3 of HIV Newsline

An Alphabetical Listing of Article Titles and Subjects Covered in the Third Year of Publication

Decmber 1997

In the past year HIV Newsline has provided its readers -- 27,566 office-based clinicians and other healthcare providers -- with 174 pages of timely information on the latest advances in the treatment of patients with HIV infection, 14 pages more than the previous year. The dissemination of this information -- at no charge to recipients -- has been made possible by unrestricted educational grants from the sponsors listed below. Their continuing support in 1998 will enable us to continue to fulfill the editorial mission that Dr. Paul A. Volberding, Editor-in-Chief of HIV Newsline, set forth in our first issue: "To provide clinicians with pertinent, practical, up-to-the-minute information on the diagnosis and long-term management of one of the most complex disease entities ever confronted by healthcare providers."

Over the past year HIV Newsline has published articles, editorials, late-breaking news items, and brief commentaries on a wide range of subjects, from the management of pain in end-stage HIV disease to the diagnosis and treatment of multidrug-resistant TB. We devoted one entire issue to HIV disease in women and children, and another to the immediate future of antiretroviral therapy.

In response to overwhelming demand from our readers, their patients, and AIDS service organizations, we reprinted and distributed 7,500 copies of "Mastering Combination Therapy," a Pull Out and Save feature that appeared in the April issue of our sister publication, AIDS Care. At her specific request, we added President Clinton's new AIDS czar -- and all the members of the President's AIDS Advisory Council -- to our mailing list.

We will continue to provide readable, relevant, reliable information to our readers in the coming year -- to assist them in providing their patients with continuing care that is clinically sound, cost-effective, and compassionate.

Advertisement

The publication of HIV Newsline is supported by unrestricted educational grants from:

Glaxo Wellcome

Bristol-Myers Squibb

Roche Laboratories

Amgen

Pfizer


The following index is arranged alphabetically by article title and by subject matter. Page numbers are provided for all entries except those that come from the unpaginated Pull Out and Save inserts that appear in every issue of HIV Newsline. The titles and subject matter of those inserts are listed by issue number.


Index: HIV Newsline, Volume 3

ALPHABETICAL LISTING | PULL-OUT INSERTS

SUBJECT LISTING:

Antiretrovirals

Opportunistic Infections and Other Conditions

Prevention / Transmission | Pediatrics

Case Studies | General


Alphabetical ListingPage

ACTG 268: gradual vs. routine initiation of PCP prophylaxis

27
A good year, and the promise of a better one131
A kiss is just a kiss107
Antiretroviral therapy in children96
Antiretroviral therapy in pregnant women 86
Approval sought for new formulation of saquinavir64
At last, a protease inhibitor for children18
Broad-based prevention programs have little impact on high-risk behavior119
CDC reports substantial drop in AIDS deaths36
Challenge of multidrug-resistant TB108
Cidofovir for CMV retinitis38
Cidofovir gel heals herpes lesions137
Clinical significance of surrogate markers57
Clinton administration proposes extending Medicaid to people with HIV62
Combinations of reverse transcriptase inhibitors in children92
Compliance: How you can help67
Drug-drug interactions -- an update140
Drug-resistant TB: Who is at risk?115
Enthusiasm tempered by caution51
Enhancing saquinavir levels with ritonavir60
First genotypic test for HIV resistance139
Gammaglobulin prevents infections141
Guidelines for administration of protease inhibitors and rifampin in HIV-positive patients with TB116
Highlights of the 4th Conference 19
HIV/AIDS debate is over3
HIV found in patients with "undetectable" viral levels141
In treating MAC, less may be more58
Isoniazid in HIV-positive patients at high risk for TB113
Is resistance always a bad thing?59
Joan J: A treatment-naïve patient who isn't naïve about treatment options121
John L: A previously untreated patient with a CD4 count above 50010
Low-dose AZT is effective in children92
More on how HIV enters cells137
Nevirapine in combination with protease inhibitors16
New formulation of saquinavir138
New macrolide inhibits late-stage HIV replication63
Next generation of antiretroviral agents73
Next generation of antiretroviral agents -- an update143
Oral AZT may be equal to IV during delivery95
Oral suspension of itraconazole effective against refractory candidiasis14
Oxandralone for wasting syndrome33
Paramomycin ineffective against cryptosporidiosis34
Peter S: An extensively treated patient with rising viral load29
Predictors of TB infection113
Preventing vertical transmission: A wise investment83
Problem of azole-resistant candidiasis24
Problem of protease resistance52
Protease inhibitor resistance and salvage therapy132
Regression of PML in an aggressively treated patient34
Risk factors and perinatal transmission94
Skills-building prevention programs118
Smoking increases risk of cryptococcosis37
Study finds treatment of pain inadequate in AIDS patients37
Transmission can be reduced among IVDUs120
  
Pull-Out InsertsIssue
Starting your patient on an antiretroviral regimenI
Guide to management of severe pain in HIV-infected patientsII
Strategies to establish and maintain optimal adherenceIII
U.S. Public Health Service recommendationsfor use of antiretroviral drugs during pregnancyIV
Foods that can be eaten in conjunction with CrixivanV
Optimal antiretroviral therapy for HIV infectionVI
  
Subject ListingPage
(Listed in temporal order of publication)
Antiretrovirals

Nevirapine in combination with protease inhibitors

16
At last, a protease inhibitor for children18
Highlights of the 4th Conference on Retroviruses19
Management of pain in end-stage HIV disease39
Enthusiasm tempered by caution51
Problem of protease resistance52
Is resistance always a bad thing?59
Enhancing saquinavir levels with ritonavir60
New macrolide inhibits late-stage HIV replication63
Approval sought for new formulation of saquinavir64
Compliance: How you can help67
Next generation of antiretroviral agents73
Antiretroviral therapy in pregnant women86
Low-dose AZT is effective in children92
Triple-drug therapy in infants93
Oral AZT may be equal to IV during delivery95
Antiretroviral therapy in children96
Guidelines for administration of protease inhibitors and rifampin in HIV-positive patients with TB116
Protease inhibitor resistance and salvage therapy132
New formulation of saquinavir138
Next generation of antiretroviral agents -- an update143
  
Opportunistic Infections and Other Conditions

Oral suspension of itraconazole effective against refractory candidiasis

14
Problem of azole-resistant candidiasis24
ACTG 268: gradual vs. routine initiation of PCP prophylaxis27
Oxandralone for wasting syndrome33
Paramomycin ineffective against cryptosporidiosis34
Regression of PML in an aggressively treated patient34
Smoking increases risk of cryptococcosis37
Cidofovir for CMV retinitis38
In treating MAC, less may be more58
Triple-drug therapy in infants93
Challenge of multidrug-drug resistant TB108
Isoniazid in HIV-positive patients at high risk for TB113
Predictors of TB infection113
Drug-resistant TB: Who is at risk?115
Guidelines for administration of protease inhibitors and rifampin in HIV-positive patients with TB116
Cidofovir gel heals herpes lesions137
Gammaglobulin prevents infections141
  
Prevention / Transmission

Preventing vertical transmission: A wise investment

83
Risk factors and perinatal transmission94
A kiss is just a kiss107
Skills-building prevention programs118
Broad-based prevention programs have little impact on high-risk behavior119
Transmission can be reduced among IVDUs120
  
Pediatrics

At last, a protease inhibitor for children

18
Combinations of reverse transcriptase inhibitors in children92
Low-dose AZT is effective in children92
Triple-drug therapy in infants93
Oral AZT may be equal to IV during delivery95
Antiretroviral therapy in children96
  
Case Studies

John L: A previously untreated patient with a CD4 count above 500

10
Peter S: An extensively treated patient with rising viral load29
Joan J: A treatment-naïve patient who isn't naïve about treatment options121
  
General
HIV/AIDS debate is over3
CDC reports substantial drop in AIDS deaths36
Study finds treatment of pain inadequate in AIDS patients37
Management of pain in end-stage HIV disease39
Clinical significance of surrogate markers57
Clinton administration proposes extending Medicaid to people with HIV62
First genotypic test for HIV resistance139
HIV found in patients with "undetectable" viral levels141
More on how HIV enters cells137
Drug-drug interactions -- an update140





  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by San Francisco General Hospital. It is a part of the publication HIV Newsline.
 

Tools
 

Advertisement